SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-22-081393
Filing Date
2022-07-21
Accepted
2022-07-21 07:36:31
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 tm2221356d1_424b5.htm 424B5 365531
2 GRAPHIC tm2221356d1_424b5img001.jpg GRAPHIC 14887
3 GRAPHIC tm2221356d1_424b5img01.jpg GRAPHIC 4752
  Complete submission text file 0001104659-22-081393.txt   393996
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-264966 | Film No.: 221095578
SIC: 2834 Pharmaceutical Preparations